VIEMED HEALTHCARE, INC. (VMD) Gross Margin
- Gross margin · 12 months: Value 57.47%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 57.47% | Gross profit / revenue. Period ending 2026-06-30. $173.32M ÷ $301.61M × 100 ≈ 57.47% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 173.32M USD | Gross Profit |
| Revenue | 301.61M USD | |
| Cost of products and services | 128.28M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $173.32M | $301.61M | $128.28M | 57.47% |
| 2026-03-31 | $165.01M | $286.56M | $121.56M | 57.58% |
| 2025-12-31 | $155.46M | $270.28M | $114.82M | 57.52% |
| 2025-09-30 | $147.49M | $254.79M | $107.30M | 57.89% |
| 2025-06-30 | $140.52M | $240.88M | $100.36M | 58.33% |
| 2025-03-31 | $136.68M | $232.79M | $96.11M | 58.71% |
| 2024-12-31 | $133.20M | $224.26M | $91.05M | 59.40% |
| 2024-09-30 | $129.18M | $214.30M | $85.13M | 60.28% |
| 2024-06-30 | $125.37M | $205.70M | $80.33M | 60.95% |
| 2024-03-31 | $118.58M | $194.04M | $75.46M | 61.11% |
| 2023-12-31 | $112.78M | $183.01M | $70.22M | 61.63% |
| 2023-09-30 | $103.57M | $169.78M | $66.21M | 61.00% |
| 2023-06-30 | $94.66M | $156.13M | $61.48M | 60.63% |
| 2023-03-31 | $88.94M | $146.13M | $57.19M | 60.86% |
| 2022-12-31 | $84.68M | $138.83M | $54.15M | 60.99% |
| 2022-09-30 | $81.45M | $133.29M | $51.84M | 61.11% |
| 2022-06-30 | $78.18M | $126.81M | $48.64M | 61.65% |
| 2022-03-31 | $75.41M | $120.90M | $45.49M | 62.37% |
| 2021-12-31 | $73.41M | $117.06M | $43.65M | 62.71% |
| 2021-09-30 | $72.93M | $116.30M | $43.38M | 62.70% |
| 2021-06-30 | $74.00M | $120.46M | $46.47M | 61.43% |
| 2021-03-31 | $82.30M | $135.92M | $53.62M | 60.55% |
| 2020-12-31 | $80.11M | $131.31M | $51.20M | 61.01% |
| 2020-09-30 | $75.18M | $121.56M | $46.38M | 61.85% |
| 2020-06-30 | $69.77M | $108.48M | $38.70M | 64.32% |
| 2020-03-31 | $58.48M | $85.95M | $27.46M | 68.05% |
| 2019-12-31 | $56.01M | $80.26M | $24.25M | 69.78% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | $50.45M | $68.62M | $18.17M | 73.52% |
| 2018-12-31 | $47.77M | $64.46M | $16.69M | 74.11% |
| 2018-09-30 | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |